企业QQ
官方微信
| 货号： | 99/624 |
大连立方化学为WHO/ NIBSC--英国国家生物标准与检定所标准品特许经销商，渠道正规；WHO/ NIBSC满足制药企业各种标准参照、参考需求。
我们以最优质的渠道为您提供最优质的服务！
杜绝暴利，节约每一分科研经费！
WHO生物标准品是世界卫生组织（WHO）制订了在疾病预防、治疗和诊断中用到的生物制品的国际标准品和参考试剂，而这些生物制品仅通过化学方法不能完全鉴定。这类标准物质已在全球范围内使用超过60年。1848年以后，WHO生物学标准化委员会（ECBS），建立和制备了数百种标准品。
WHO国际标准品的研究和生产是来自于全球最优秀机构的协作，包括全世界各国国家实验室、制药企业、大学和医院实验室。供试材料不仅涵盖整个研究设计的目标，还包括用于评价可靠性的有编码的重复材料。
有关世卫组织WHO生物标准品目录，请点击查询WHO官方网站：http://www.who.int/bloodproducts/catalogue/Alph2015.pdf?ua=1
NIBSC--英国国家生物标准与检定所（National Institute for Biological Standards and Control, NIBSC），同时它又是世界卫生组织WHO的一个国际标准品供应中心，它的核心工作是制备、保存和分发WHO用于检测全球生物制品质量的标准品。NIBSC制备的流感毒株和检测抗原、抗血清标准品，保障了各厂家顺利的研究和生产。NIBSC提供对投入英国市场的生物药品的独立测试，尤其是用于英国儿童免疫计划的疫苗；它同时也是欧盟控制药品进入欧盟市场的官方药品控制实验室(OMCL)。 如果出现不能满足药品存放要求或患者出现不良反应等问题，NIBSC 也可对已投入欧盟市场的产品进行检验。
主要产品：流感毒株和检测抗原、抗血清标准品随货可提供资料：使用说明书（Instructions for use）详细资讯，
请点击NIBSC官方网站： www.nibsc.org
所有WHO/ NIBSC产品目录下的产品，我们均以最优质的渠道、最优惠的价格为您提供最优质的服务！
订购流程：咨询客服确定产品→告知客服人员收货开票信息→确立合同→等待收货→转账付款
咨询/订购电话：13504241390 立方化学
0411-84631233
在线客服： QQ ：3324578804
附件：部分产品目录
货 号 产品名称
13/172 Lupus Anticoagulant (1st International Reference Panel)
14/13/132 Antibodies, Human, to Toxoplasma gondii (4th International Standard)
13/132 Antibodies, Human, to Toxoplasma gondii (4th International Standard)
13/146 C-Peptide, Human (1st International Standard).
13/204 TNF Rec II- FC Fusion protein (1st International Standard)
13/212 Diphtheria Toxoid for use in Flocculation Test (3rd International Standard)
13/246 Meningococcal serogroup A polysaccharide (1st WHO International Standard).
14/114 JC Virus (JCV) DNA (1st International Standard)
14/148 Human Coagulation Factor IX Concentrate (5th International Standard).
14/156 Meningococcal group X polysaccharide (1st WHO International Standard)
14/212 BK Virus (BKV)(1st International Standard)
14/300 High titre anti-A and anti-B in serum (WHO Reference Reagent).
15/220 Anti-EBOV plasma, human (WHO Reference Reagent)
15/222 EBOV RNA NP-VP35-GP (WHO Reference Reagent)
15/224 EBOV RNA VP40-L (WHO Reference Reagent)
15/240 Erythropoietin Antibody Reference Panel A (1st International Standard)
15/242 Erythropoietin Antibody Reference Panel B(1st International Standard)
13/122 Erythropoietin Antibody Reference Panel Negative Control Antibody
(1st WHO Reference Panel)
03/178 Vitamin B12, Serum Folate and holoTC (International standard)
09/172 Blood coagulation Factors II, VII, IX, X Plasma
(4th International Standard 2010)
14/B655-01 QCRVZVQC1-Anti VZV: Quality Control Serum: Sample 1
14/198-001 HBV,HCV,HIV Multiplex
11/234 Immunoglobulin E(IgE) human serum (3rd International Standard)
15/136 EBOV RNA NP-VP35-GP in-run control
15/138 EBOV RNA VP40-L in-run control
14/240-002 British Working Standard for Anti-HCV
14/174 Botulinum Type A Antitoxin, Equine
NIBSC标准品 产品列表：
00/410 MAPREC assay of poliovirus type 1 (Sabin).100% 480-A, 525-C DNA(1st International Reference Preparation)
00/416 Low Mutant Virus Reference for MAPREC assay of poliovirus type 1 (Sabin)(1st International Reference Preparation)
00/418 MAPREC assay of poliovirus type 1 (Sabin) (1st International Standard)
00/422 High Mutant Virus Reference for MAPREC assay of poliovirus type 1 (Sabin)(1st International Reference Preparation)
00/440 Influenza Antiserum A/Singapore/1/57 (H2)
00/442 Influenza anti B/Yamanashi/166/98 Serum (sheep)
00/464 Streptokinase (3rd International Standard 2001)
00/500 Botulinum Type A-E Antitoxin, Human Serum
00/530 Influenza Virus infectious B/Sichuan/379/99
00/542 Influenza anti- A/Chick/Scotland/59 (H5N1) Serum
00/544 Influenza Virus infectious B/Victoria/504/00
00/546 Influenza Antigen B/Johannesburg/5/99
00/552 Influenza Antigen A/Duck/Singapore-Q/F119-3/97 (H5N3)
00/556 Influenza anti-B/Johannesburg/5/99/ Serum
00/562 Hepatitis A Virus for Nucleic Acid Amplification Techniques(2nd International Standard)
00/572 Interferon Beta (Human, rDNA, Glycosylated) (3rd International standard)
00/574 Interferon Beta SER17 Mutein (Human, rDNA derived)
00/576 Interferon Beta (Human, Fibroblast-derived, Glycosylated)
00/614 Influenza virus infectious B/Guangdong/120/2000
007SP Human Anti-Pneumococcal capsule Reference Serum (1st International Standard)
01/412 Anti-Meningococcal Immunotype L3,7,9 Monoclonal Antibody
01/420 Interleukin-17 (Human rDNA derived)(International Reference Reagent)
01/424 Vascular Endothelial Growth Factor, Human rDNA derived
01/426 Meningococcal group Y polysaccharide
01/428 Meningococcal serogroup W polysaccharide
01/450 Influenza anti B/Guangdong/120/2000 Serum
01/452 Influenza anti A/Panama/2007/99 (H3N2) HA serum
01/506 Botulinum type F antitoxin, equine
01/508 Botulinum type C antitoxin, equine
01/510 Botulinum Antitoxin Equine Type D
01/512 Botulinum type G antitoxin, equine
01/514 Anti-Meningococcal Serosubtype P1.7 Monoclonal Antibody
01/528 Oral Poliovaccine Sabin Type 1 reference strain [LS-c, 2ab strain] (Panel of 5 ampoules)
01/530 Oral Poliovaccine Sabin Type 2 reference strain (Panel of 5 ampoules)
01/532 Oral Poliovaccine Sabin Type 3 reference strain (Panel of 5 ampoules)
01/538 Anti-Meningococcal Serosubtype P1.16 mAb
01/546 Influenza Antigen B/Guangdong/120/2000
01/572 Anti-D Immunoglobulin(2nd International Standard)
01/580 Thrombin, human(2nd International Standard)
01/600 Anti-Toxoplasma IgG, Human(International Standard)
01/602 Anti-Parvovirus B19, plasma, human(2nd International Standard)
01/612 Influenza Virus infectious B/Hawaii/10/01
01/614 Influenza Antigen A/New Caledonia/20/99
02/102 Influenza anti A/Panama/2007/99 Serum
02/144 Anti-Meningococcal Serosubtype P1.15 mAb
02/148 Anti-Meningococcal Serosubtype P1.4 mAb
02/168 Prekallikrein Activator (PKA), Human(2nd International Standard)
02/178 Anti-Meningococcal Serosubtype P1.2 mAb
02/180 Anti-Meningococcal Serotype P2.2a mAb
02/182 Anti-Japanese Encephalitis Virus Plasma, Human
02/184 Anti-Japanese Encephalitis (Anti-JE) Virus Negative Control Plasma, Human
02/206 Factor XIII Plasma, Human (1st International Standard)
02/210 HIV (antibody), 1st International Reference Panel
02/226 IVIG negative control for use with IVIG + anti-D(International Reference Reagent)
02/228 IVIG + anti-D for use with negative control IVIG(International Reference Reagent)
02/230 Biotinylated Brad-5 (Bio-Brad-5)
02/232 Tetanus Toxoid (Non-Adsorbed)
02/254 Insulin-like Growth Factor-1, recombinant, human, for immunoassay(1st International Standard)
02/262 Influenza Virus infectious B/Brisbane/32/2002
02/264-005 HCV RNA Working Reagent for Nucleic Acid Amplification Techniques
02/286 Vascular Endothelial Growth Factor 165 (VEGF165)(recDNA, human sequence)(International Reference Reagent)
02/294 Influenza Antiserum A/chick/Italy/1347/99 (H7N1)
02/306 Polio Virus Sabin Types 1, 2 and 3(2nd International Reference Reagent)
02/308 Anti-Meningococcal Serotype P3.4 mAb
02/310 Anti-Meningococcal Serotype P3.15 mAb
02/318 Botulinum Antitoxin Equine Type E
02/320 Anti-Meningococcal Serosubtype P1.3 mAb
02/336 Influenza Antigen A/New Caledonia/20/99
02/338 Influenza anti A/Panama/2007/99 Serum
02/342 Protein C Plasma, Human(2nd International Standard)
03/104-016 HTLV-1 (antibody) Monitor Sample
03/110 Influenza anti B/Shangdong/9/97 Serum
03/114 Anti-Meningococcal Serosubtype P1.1 mAb
03/116 Blood Coagulation Factor V, Plasma Human (1st International Standard)
03/124 Thrombopoietin ( Human rDNA derived)
03/142 Anti-Meningococcal Serosubtype P1.14 mAb
03/148 Keratinocyte growth factor (KGF, FGF-7)(24-163)(1st International Reference Reagent)
03/150 Keratinocyte Growth Factor (KGF,FGF-7)(1st International Reference Reagent)
03/152 Anti-HPA-1a (International Standard)
03/164 Anti-B minimum potency reference preparation(International Standard)
03/178 Vitamin B12, Serum Folate and holoTC (International standard)
03/182 Anti-Meningococcal Serotype P3.21 mAb
03/188 Anti-A minimum potency reference preparation(International Standard)
03/190 Anti-HPA-3a(minimum potency)(International Reference Reagent)
03/192 Thyroid-Stimulating Hormone, Recombinant, Human, for Bioassay (1st International standard)
03/198 Influenza Virus infectious A/Kumamoto/102/02
03/200 Interleukin - 18 (Human rDNA derived)(International Reference Reagent)
03/210 Anti-Meningiococcal Serosubtype P1.6 mAb
03/212 Influenza anti A/Wyoming/03/03 Serum
03/220 Influenza Antigen A/Wyoming/03/03
03/224 Anti-Meningococcal Serosubtype P1.10 mAb
03/226 Anti-Meningococcal Serosubtype P1.5 mAb
03/228 Protein S, Plasma, Human(2nd International Standard)
03/236 Anti-Meningococcal Serosubtype P1.13 mAb
03/242 Influenza anti A/Puerto Rico/8/34 (H1N1) HA Serum
03/244 Influenza Antiserum A/chick/Germany/N/49
03/258 Influenza Antigen A/New Caledonia/20/99 (IVR-116)
03/262 Hepatitis B Surface Antigen subtype adw2, genotype A (International Reference Panel)
04/102 Blood Coagulation Factor XI Plasma, Human(1st International Standard)
04/122 Anti-Meningococcal Serosubtype P1.12 mAb
04/132 IVIG + Anti-D for use with negative control IVIG
04/140 IVIG Negative Control for use with IVIG & Anti-D
04/150 Tetanus Toxoid For Flocculation Test(2nd International Standard)
04/160 Influenza Virus infectious NYMC X-147
04/166 TNF-related Apoptosis-Inducing Ligand (trail), Human, rDNA-derived(1st International Reference Reagent)
04/170 Influenza Virus infectious A/Wellington/1/2004
04/172 Influenza Virus infectious IVR-139
04/176 Plasmodium falciparum DNA for NAT Assays(1st International Standard)
04/198 Anti-Meningococcal Serotype P3.1 mAb
04/200 Parathyroid hormone 1-34 ,Recombinant, Human(International Standard)
04/202 Influenza Antigen B/ Jiangsu/10/2003
04/214 Influenza anti A/Vietnam/1194/04 (NIBRG-14) HA Serum (sheep SH440&SH442)
04/224 Factor V Leiden, Human gDNA, 1st International Genetic Reference Panel 2004
04/228 Influenza anti B/ Neuraminidase Serum
04/230 Influenza anti N1 Neuraminidase Serum
04/242 Influenza anti B/Jiangsu/10/2003 HA Serum (sheep)
04/246 Anti-Meningococcal Serogroup W-135 mAb
04/248 Anti-Meningococcal Serosubtype P1.19 mAb
04/252 Protein C Concentrate, Human(1st International Standard)
04/258 Influenza anti N2 Neuraminidase Serum(prepared from A/Wyoming/3/2003)
04/260 Influenza anti A/New Caledonia/20/99 HA Serum (sheep)
04/262 Influenza anti A/New York/55/2004 HA Serum (sheep)
04/264 Influenza Antigen A/New York/55/2004 (H3N2) (NYMC X-157)
05/102 Influenza Virus infectious NYMC BX-7
05/106 Anti-HPA-1a minimum potency reagent(2nd International Reference reagent)
05/110 Influenza Virus infectious A/California/7/2004
05/112 Low Molecular Weight Heparin for Molecular Weight Calibration (2nd International Standard).
05/122 Syphilitic plasma IgG (human)(1st International Standard)
05/130 Prothrombin Mutation G20210A, Human gDNA(1st International Genetic Reference Panel 2005)
05/132 Syphilitic plasma IgG and IgM (human)(1st International Standard)
05/134 Anti-human papillomavirus type 16 serum (1st International Standard)
05/138 Influenza Virus infectious B/Shanghai/361/2002
05/162 Alpha-1-Antitrypsin, plasma derived(1st International standard)
05/190 Anti Meningococcal Serosubtype P1.9 Monoclonal Antibody
05/192 Anti Meningococcal Serotype P2.2b Monoclonal Antibody
05/234 Influenza Antigen A/Hiroshima/52/2005 (H3N2) (IVR-142)
05/236 Influenza anti A/Wisconsin/67/2005 Serum (sheep)
05/242 IVIG, Anti-D and Negative Control Panel
05/252 Influenza anti B Neuraminidase Serum (Sheep SH463)
06/108 Influenza Virus infectious IVR-116
06/114 Influenza Virus Infectious A/PR/8/34
06/124 Monoclonal Antibody for Serotyping Bordetella pertussis Fimbrial Antigen 2 (1st International Standard)
06/128 Monoclonal Antibody for Serotyping Bordetella pertussis Fimbrial Antigen 3 (1st International Standard)
06/140 Pertussis Antiserum(human)1st IS-WHO international Standard.
06/142 Pertussis Antiserum (Human) 1st WHO Reference Reagent
06/164 Influenza Virus infectious 1 VR-142
06/166 Antithrombin Concentrate, Human (3rd International Standard)
06/170 Influenza Antigen A/New Caledonia/20/99
06/192 Influenza anti A/turkey/Turkey/1/05 (NIBRG-23) HA serum(sheepSH465 & SH466)
06/202 Human Papillomavirus (HPV) Type 16 DNA (1st International Standard)
06/206 Human Papillomavirus (HPV) Type 18 DNA (1st International Standard)
06/242 Influenza Virus Infectious NYMC X-161B (A/Wisconsin/67/2005 HGR)
07/102 Influenza Antigen A/Solomon Islands/3/2006 (H1N1)(IVR-145)
07/104 Influenza anti A/Solomon Islands/3/2006 (H1N1) (IVR-145) HA Serum (sheep 467,468,469,470)
07/112 Influenza Antigen A/turkey/Turkey/1/2005 (H5N1) NIBRG-23
07/132 Influenza Virus infectious B/Malaysia/2506/2004
07/144 Influenza Virus infectious IVR-145,
07/146 Influenza anti A/HongKong/1073/99 like (H9) HA Serum (sheep)
07/148 Influenza anti A/Vietnam/1194/04 (H5N1) HA Serum
07/150 Human Plasma Anti-Influenza H5N1 (1st International Standard)
07/164 Anti-hepatitis B surface antigen(Anti-HBs) immunoglobulin (2nd International Standard)
07/182 Blood Coagulation Factor IX Concentrate, Human (4th International Standard)
07/184 Influenza anti B/Malaysia/2506/2004-HA Serum (sheep)
07/202 Recombinant soluble transferrin receptor (rsTfR)(1st WHO Reference Reagent)
07/214 Positive Control for use in flow cytometry cross matching (FCXM)
07/216 Diphtheria Toxoid (Adsorbed) (4th International Standard)
07/222 RhD/SRY Plasma DNA sensitivity standard (1st International Reference Reagent)
07/226 Influenza Virus Infectious A/New Caledonia/20/99
07/228 Blood Coagulation Factor VIIa, Concentrate, Human, 2nd International Standard”
07/246 Influenza Virus Infectious IVR-147
07/268 Influenza Virus Infectious B/Brisbane/3/2007
07/270 BCG Vaccine of Danish 1331 sub-strain (1st WHO Reference Reagent)
07/272 BCG Vaccine of Tokyo 172 sub-strain(1st WHO Reference Reagent)
07/274 BCG Vaccine of Russian BCG-I sub-strain(1st WHO Reference Reagent)
07/278 Influenza anti A/mallard/Netherlands/12/2000 (H7) HA serum (NIBRG-60) (sheep SH474 AND SH475)
07/286-012 Hepatitis B Surface Antigen Monitor Sample
07/288-012 Hepatitis B Surface Antigen British Working Standard 0.2 IU/ml
07/290 Influenza Antigen A/Anhui/1/05 (H5N1) IBCDC-RG-6
07/294-005 Norovirus GII for Nucleic Acid Amplification Techniques
07/296-005 Influenza Virus (A/Christchurch/1/2003, H1N1) for Nucleic Acid Amplification Techniques
07/298-004 Influenza Virus (A/Wyoming/3/2003, H3N2) for Nucleic Acid Amplification Techniques
07/300-004 Influenza Virus (B/Jiangsu/10/2003) for Nucleic Acid Amplification Techniques
07/304 Anti-D for assuring operator and test performance
07/306 Anti-A and anti-B in IVIG: Positive control for haemagglutination tests (International Reference Reagent)
07/316 Blood Coagulation Factor VIII and Von Willebrand Factor in Plasma (6th I.S.)
07/318 Meningococcal Group C Polysaccharide
07/326 Blood Coagulation Factors II, IX,and X Concentrate, 6th British Working Standard.
07/328 Unfractionated Heparin (6th I.S.)
07/336 Influenza Antigen A/mallard/Netherlands/12/00(H7N3) NIBRG-60
07/338 Influenza anti A/Anhui/1/05 (H5)HA serum (IBCDC-RG6) (Sheep SH477)
07/348 Influenza Virus infectious NYMC X-171B
07/350 Blood Coagulation Factor VIII Concentrate (8th I.S.)
07/358 Influenza Virus infectious NIB-50
07/362 Influenza Virus infectious IVR-149
07/364 Chorionic Gonadotrophin, (5th International Standard)
07/B498-16 QCRHBclgMQC1-IgM Anti-HBc Quality Control Serum: Sample1
08/100 Influenza Antigen A/Brisbane/59/2007 (IVR-148) (H1N1)
08/108 Influenza Virus Infectious NIBRG-91
08/114-005 Human Adenovirus serotype 2 for Nucleic Acid Amplification Techniques
08/118-004 Parainfluenza Virus serotype 3 for Nucleic Acid Amplification Techniques
08/120-005 Human Respiratory syncytial virus A2 for Nucleic Acid Amplification Techniques
08/126 Influenza anti A/turkey/Turkey/1/05(N1) NA Serum (NIBRG-74) (Sheep SH485)
08/138 Influenza Virus Infectious B/Florida/4/2006
08/140 Influenza Antigen B/Florida/4/2006
08/142 Influenza anti A/Anhui/1/05 (H5) HA serum (IBCDC-RG6) (sheep SH477)
08/148 Positive control for Luminex based anti-HLA Class II serology
08/150 HIV-2 RNA(1st International Standard)
08/154 Influenza Virus Infectious NIBRG-12
08/156 Influenza Virus Infectious NIBRG-23 30060 VE3
08/158 Fragile X Syndrome gDNA (1st International Genetic Reference Panel)
08/160 Haemophilia A, Intron-22 inversion, gDNA, (1st International Genetic Reference Panel)
08/174-006 Human Coxsackie B4 for Nucleic Acid Amplification Techniques
08/176-004 Parainfluenza Virus serotype 1 for Nucleic Acid Amplification Techniques
08/178-004 Parainfluenza Virus serotype 2 for Nucleic Acid Amplification Techniques
08/180-004 Parainfluenza virus serotype 4 for Nucleic Acid Amplification Techniques
08/184 Influenza Antigen B/Malaysia/2506/2004
08/202 Influenza anti A/chick/Hong Kong/G9/1997/(H9) HA serum (NIBRG-94)(H9N1)
08/204 Thyroid Stimulating Antibody (2nd I.S.)
08/208 Influenza Antigen Hong Kong/1073/99 (H9N2)
08/210 Influenza anti A/Cambodia/R0405050/2007 (H5) HA serum (NIBRG-86)
08/214 Meningococcal Serogroup C polysaccharide (1st International Standard)
08/216 Influenza Antigen A/Cambodia/RO405050/2007 (H5N1)
08/218 Tetanus Toxoid Adsorbed (4th International Standard)
08/224-005 Human Herpes Simplex virus type 1 for Nucleic Acid Amplification Techniques
08/226-005 Human Herpes Simplex virus type 2 for Nucleic Acid Amplification Techniques
08/228 Influenza Antigen A/chick/Hong Kong/G9/1997 (H9N2) NIBRG-91
08/230 Streptodornase (2nd International Standard)
08/246 Influenza anti A/Brisbane/10/2007- like HA serum
08/256 C1- Inhibitor, Concentrate (1st International Standard)
08/258 Antithrombin, Plasma (3rd International Standard)
08/262 C1 Inhibitor (Plasma)(1st International Standard)
08/266 Sex Hormone Binding Globulin.(2nd International Standard)
08/268 Influenza Antigen A/mallard/England/727/2006 (H2N3)NIBRG-107
08/278 Influenza Antigen A/Brisbane/10/2007-like (Prepared from A/Uruguay/716/2007 (NYMC X-175C))
08/282 Follicle-Stimulating Hormone, human, recombinant, for bioassay (2nd International Standard)
08/298 Influenza Virus Infectious B/Brisbane/33/2008 30720 E5
08/300 Influenza Virus Infectious IVR-148
08/304 Influenza virus infectious NYMC X-175C
08/310-005 Varicella Zoster Virus(Type B) Working Reagent for Nucleic Acid Amplification Testing (NAT)
08/314-006 Human Cytomegalovirus for Nucleic Acid Amplification Techniques (AD169)
08/316-005 Epstein-Barr Virus for Nucleic Acid Amplification Techniques
08/318-005 Human Norovirus GI Working Reagent for Nucleic Acid Amplification Testing
08/320-007 Human metapneumovirus Working Reagent for Nucleic Acid Amplification Testing
08/322-004 Human Parechovirus Working Reagent for Nucleic Acid Amplification Testing
08/356 Influenza anti A/Japan/305/57 (H2) HA serum (A/Singapore/1/57-Like) (Sheep SH398)
08/362 Influenza Antigen A/New York/107/2003 (H7N2)NIBRG-109
09/100 Influenza anti A/mallard/England/727/2006 (N3) NA serum (NIBRG-107) (Sheep SH503)
09/110 Parvovirus B19 DNA Nucleic Acid Amplification Technology(NAT) based assays Genotype Panel(1st International Standard)
09/112 Negative Control for use in flow cytometry cross matching (FCXM) and anti-HLA serology
09/130 Influenza Virus Infectious NIBRG-122
09/136 Granulocyte colony Stimulating Factor (Human, rDNA Derived)(2nd International Standard)
09/138 Genetic Reference Panel, for the quantitation of BCR-ABL translocation by RQ-PCR (1st I.S.)
09/140 Prader Willi & Angelman Syndromes, Human gDNA,(1st International Genetic Reference Panel)
09/148 Influenza anti A/New York/107/2003 (H7) HA serum (Sheep SH504 and SH505)
09/154 Clostridium sordellii (Gas-gangrene) Antitoxin, Equine,(1st International standard)
09/162 Human Cytomegalovirus (HCMV) for Nucleic Acid Amplification Techniques (1st International Standard)
09/170 Anti-Meningococcal factor H binding protein variant 1 (JAR4) monoclonal antibody
09/172 Blood coagulation Factors II, VII, IX, X Plasma (4th International Standard 2010)
09/174 Influenza Antigen A/California/7/09 (H1N1)v (NYMCX-179A)(Cell Derived)
09/182 VWF Factor Concentrate (2nd International Standard)
09/184 Influenza Antigen A/Vietnam/1194/2004 (H5N1) NIBRG-14
09/186 Chagas (anti-Trypanosoma cruzi II) antibody in human plasma(1st International Standard)
09/188 Chagas (anti-Trypanosoma cruzi I) antibody in Human Plasma (1st International Standard)
09/196 Influenza Antigen A/California/7/09 (H1N1)v (NIBRG-121xp) (Egg Derived)
09/222 Human anti-Haemophilus influenzae b reference serum
09/234 Transforming Growth Factor-BETA 3 (Human, rDNA derived TGF-ß 3) (1st International Standard)
09/236 Influenza Virus Infectious IVR-153
09/242 Fibrinogen Concentrate (B)(2nd International Standard)
09/260 Epstein-Barr Virus for Nucleic Acid Amplification Techniques(1st International Standard)
09/264 Fibrinogen Plasma (D)(3rd International Standard)
09/266 GLIAL CELL-DERIVED NEUROTROPHIC FACTOR (GDNF), human, rDNA-derived
09/268 Influenza Virus Infectious NIBRG-121xp
09/272 Placental growth factor Ala 21 - Arg 149, human, rDNA-derived (PlGF, PlGF-1)
09/274 Influenza Virus Infectious NYMC X-185
09/280 Influenza Virus Infectious NIB-64
09/284 Anti-Human Neutrophil Antibody 1a WHO Reference Reagent
09/296 Pro-Insulin, human (1st International Standard)
09/304 Influenza Virus Infectious IVR-155
09/306 Influenza Virus Infectious NIBRG-147
09/308 Influenza serology antigen reagent for haemagglutination inhibition assay Pandemic H1N1 2009 (X179A)
09/310 Influenza Antigen A/Wisconsin/15/09 (H3N2) (NYMCX-183)
09/316 Influenza Anti B Neuraminidase Serum (B/Florida/4/2006)
09/B558-06 QCRHIV1RTDQC1- Anti-HIV1 Quality Control Serum: Sample 1 for Rapid Test Devices
09/B584-12 QCRTHAVQC1-Total Anti-HAV Quality Control Serum: Sample1
09/B588-07 QCRTOXOQC1-Anti-Toxoplasma Quality Control Serum: Sample 1
10/104 Reteplase Reference Material
10/120 Influenza Anti A/Brisbane/59/2007 (IVR 148)(H1N1) HA serum (sheep 516 and 517)
10/128 Diphtheria Polyclonal Antibody
10/130 Diphtheria Monoclonal Antibody
10/132 Tetanus Polyclonal Antibody
10/134 Tetanus Monoclonal Antibody
10/136-001 HLA-DRB1 Genotyping Reference Panel
10/140 Anti-human papillomavirus[HPV] 18 serum (1st International Standard)
10/142 Negative control for Luminex based anti-HLA serology
10/152 HIV-1 RNA (3rd International standard)
10/154-005 Anti-HCV (1 in 8 dilution)(British Working Standard)
10/176 Interleukin-29 (Interferon Lamda 1)
10/178 Endotoxin (3rd International Standard)
10/188 Factor VIII Concentrate (13th British Standard).
10/198 Anti-malaria (Plasmodium falciparum) human serum(1st International Reference Reagent)
10/202 Influenza antibody (Human) to A/California/7/2009 like (H1N1v) virus (2nd International Standard)
10/214 Influenza Anti N2 Neuraminidase Serum SH395 & SH396
10/218 Influenza Anti A/California/7/2009 (N1) NA Serum (Sheep SH 521)
10/226 Influenza Virus Infectious IVR-158
10/232 Genomic DNA for blood group genotyping RBC1(AR1R1)(International Reference Reagent)
10/234 Genomic DNA for blood group genotyping RBC12 (ODpsi)(International Reference Reagent)
10/236 Genomic DNA for blood group genotyping RBC4(OR1R2)(International Reference Reagent)
10/238 Genomic DNA for blood group genotyping RBC5(Brr)(International Reference Reagent)
10/242 Toxoplasma gondii DNA Nucleic Acid Amplification Techniques(1st International Standard)
10/252 Factor VII Concentrate(2nd International Standard)
10/258 Influenza Antigen A/California/7/2009-like(NIB-74)
10/260 Influenza Virus Infectious NIB-58
10/262 Diphtheria Antitoxin Human IgG(1st International Standard)
10/264 Hepatitis B Virus for Nucleic Acid Amplification Techniques (3rd WHO International Standard)
10/272 BCG vaccine of Moreau-RJ sub-strain(1st International Reference Reagent)
10/276 Influenza virus infectious BX-31
10/276 Influenza virus infectious BX-31
10/280 Anti-HLA Control
10/286 Follicle Stimulating Hormone, Luteinizing Hormone human, urinary for bioassay(5th International Standard)
10/B592-09 QCRTHBcQC1-Total Anti-HBc Quality Control Serum: Sample 1
10/B594-06 QCRHCVQC1-Anti-HCV Quality Control Serum: Sample1
10/B596-09 QCRHSV1QC1-Anti-HSV1 Quality Control Serum: Sample1
1050 IPV ELISA MAbs Type 1, 2 and 3 (Type 2; No: 1050)
11/106 Influenza Virus infectious A/Perth/16/2009
11/106 Influenza Virus infectious A/Perth/16/2009
11/108 Influenza Virus infectious NYMC X-187
11/108 Influenza Virus infectious NYMC X-187
11/126 Factors II and X Concentrate (4th International standard)
11/130 Influenza Virus Infectious NIBRG-14
11/130 Influenza Virus Infectious NIBRG-14
11/134 Influenza Antigen A/California/7/2009 (H1N1) Like (A/Brisbane/10/2010- cell derived)
11/170 Erythropoietin, recombinant, for Bioassay (3rd International Standard)
11/176 Low Molecular Weight Heparin 2 (3rd International Standard)
11/182-001 HBV DNA Working Reagent
11/184 High Molecular Weight Urokinase(2nd International Standard)
11/206 Influenza anti-A/Perth/16/2009 HA Serum
11/208-001 Parvovirus B19 DNA
11/210 Anti-human CD4 FITC conjugated 0.5ml
11/214 Blood Group Genotyping Reference Panel ((International Reference Reagent)
11/216 Chagas Antibody Reference Panel ( 1st International Standard)
11/218-001 MLH1/MSH2 Exon Copy Number Reference Panel
11/222 Influenza Virus Infectious NIB-79
11/226 &nbs